Blockchain in Healthcare Market to Grow at Staggering 70% CAGR until 2027 – TechSci Research

Blockchain in Healthcare Market

Need to safeguard patient healthcare data and surging cyberattacks to drive global blockchain in healthcare market through 2027

NEW YORK, NEW YORK, UNITED STATES, February 26, 2020 /EINPresswire.com/ — Need to safeguard patient healthcare data and surging cyberattacks to drive global blockchain in healthcare market through 2027

According to TechSci Research report, “Global Blockchain in Healthcare Market By Type, By Application, By End User, By Region, Competition, Forecast & Opportunities, 2027”, global blockchain in healthcare market is projected to witness a CAGR of over 70% during 2020 – 2027, on account of increasing cases of data breaches in the healthcare industry. The implementation of blockchain in healthcare industry will provide transparency on complex transactions existing between different stakeholders of clinical supply chain. Additionally, blockchain helps to manage healthcare related data without alteration, which is anticipated to drive the blockchain in healthcare market through 2027. Need for improving security and interoperability of healthcare information system is boosting the adoption of blockchain in healthcare industry.

Browse 15 market data Tables and 85 Figures spread through 110 Pages and an in-depth TOC on "Global Blockchain in Healthcare Market”

https://www.techsciresearch.com/report/blockchain-in-healthcare-market/3913.html

The global blockchain in healthcare market, globally, can be segmented based on type, application, end-user and region. Based on end user, the market can be segmented into healthcare providers, pharmaceutical companies and others. Major healthcare markets such as the US and Europe have mandated the implementation of full trace and tracking of pharma products, owing to which they account for the leading share in the market. Blockchain in healthcare market is at a nascent stage and finds applications in drug supply chain management, clinical data exchange & interoperability, claims adjudication & billing management, prescription drug abuse and others. Increasing number of counterfeit drugs in circulation and implementation of strict regulations, such as Drug Quality and Security Act (DQSA) and Falsified Medicines Directive (FMD) in the US and Europe are contributing to the leading share of drug supply chain management segment.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=3913

Customers can also request for 10% free customization on this report.

IBM Corporation, Microsoft Corp., Accenture Plc, PokitDok, Inc., Factom Inc., Healthereum, LLC, Guardtime, Proof.Work, Simplyvital Health and Farmatrust are some of the leading market players. Companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share. In 2018, IBM launched a low-cost platform to encourage the adoption of blockchain in healthcare industry.
“North America is the leading region in global blockchain in healthcare market, backed by technological advancements and regulations in place for the safety of patient data and delivery of best healthcare services. Moreover, high need for reducing healthcare costs and preventing tampering of medical data is likely to boost demand for blockchain in healthcare in the region over the course of next five years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Blockchain in Healthcare Market By Type, By Application, By End User, By Region, Competition, Forecast & Opportunities, 2027” has evaluated the future growth potential of global blockchain in healthcare market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global blockchain in healthcare market.

About TechSci Research

TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.

Contact

Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

New Age TechSci
New Age TechSci Research Pvt Ltd
+ +1 646 360 1656
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

PERTHERA AND LAZAREX CANCER FOUNDATION ANNOUNCE PARTNERSHIP TO ADVANCE PRECISION ONCOLOGY INITIATIVES

Lazarex and Perthera unite to advance Clinical Trial Access and Enrollment for Cancer Patients

HOLLISTON, MA, USA, February 26, 2020 /EINPresswire.com/ — Perthera, Inc., a Biohealth Informatics company with an Oncology Platform proven to advance patient outcomes, and Lazarex Cancer Foundation, an advocacy group whose mission is to improve patient access to cancer clinical trials, have announced the launch of their partnership today. Together, they will be focused on matching and enrolling patients in clinical trials through Lazarex’s IMPACT and CARE programs, by utilizing Perthera’s treatment-matching Artificial Intelligence (AI) technology and other elements of the Perthera Platform to advance precision medicine for cancer patients.

“We are excited to work with Lazarex Cancer Foundation, a leading organization dedicated to advancing and accelerating patient enrollment in clinical trials,” said Gary Gregory, CEO of Perthera, Inc. “Lazarex’s passion and mission align perfectly with our innovative technology Platform. Together, we form a powerful team to make a difference for patients, physicians and clinical trial sites.”

Perthera’s proprietary AI technology allows physicians to utilize comprehensive patient informatics, such as medical history and molecular profile information, to equip physicians with precisely matched therapies that are best suited to advance patient outcomes. Through Perthera’s partnership with Lazarex, patients will be matched to the most relevant clinical trials, while expanding patient access and clinical trial enrollment.

"Perthera’s Platform has been proven to advance patient outcomes from both an overall and progression-free survival perspective, and also proven to accelerate Clinical Trial enrollment by five times the national average,” said Dana Dornsife, Founder and Chairman of Lazarex Cancer Foundation. “Perthera’s exceptional capabilities are aligned with the broad reach of our CARE and IMPACT programs and this positions both organizations to deliver exemplary value to patients, physicians and our clinical trial sites across the country.”

According to the Journal of the National Cancer Institute, only 2%-4% of newly diagnosed patients participate in clinical trials. Unfortunately, finances and transportation tend to be the largest barriers in the way of these enrollments. Forbes notes that because of low enrollment, many clinical trials do not meet their targets, resulting in a significant barrier to the advancement of cancer research. Lazarex, founded by members who recognized this significant issue, provides education to patients and has created supportive programs to promote higher patient enrollment in clinical trials.

Perthera’s partnership with Lazarex aims to utilize its proven, proprietary Platform to increase clinical trial enrollment and generate real-world evidence to advance cancer research & development. To reach out to Perthera regarding their Platform and matched treatment recommendations for oncologists and patients, contact Hope@Perthera.com or call (833) 781-7810.

If you are a cancer patient, a caregiver or friend of a cancer patient interested in patient resources or learning more about the possibility of participating in a clinical trial, visit the Lazarex Cancer Foundation’s website to learn more about your options https://lazarex.org/.

About Perthera, Inc.
Perthera is the leading Therapeutic Intelligence company advancing cancer care outcomes through its Precision Oncology Platform. Their innovative technology precisely matches cancer patients with ranked therapeutic options and has been utilized at over 250+ cancer care sites and utilized by over 10% of US Oncologists. Their Precision Oncology Platform, with an AI-driven Therapeutic Intelligence Engine™, has been clinically proven to extend overall and progression-free survival rates by over two-fold for cancer patients. Perthera positions Hospitals and Physicians to harness the power of Precision Medicine to improve patient outcomes and save lives. The Perthera Platform also offers a highly comprehensive Precision Cancer database and an array of services that delivers significant value to Pharma, Drug Development, Clinical Research Organizations and Payers.

About Lazarex Cancer Foundation
Lazarex Cancer Foundation is a publicly funded 501(c)(3) charity focused on the improvement of outcomes in cancer care, giving hope, dignity, and life to advanced-stage cancer patients and the medically underserved by providing assistance with costs for FDA clinical trial participation, identification of clinical trial options, community outreach and engagement. In its 14 years, Lazarex has assisted over 5,500 patients in clinical trials.
Learn more about Lazarex at https://lazarex.org/. For any media inquiries about the Lazarex Foundation, contact Laura Evans Manatos at +1.301.379.6028 and Laura@LauraEvansMedia.com.

Gary L. Gregory
Perthera, Inc.
+1 508-397-8885
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Oncology Biosimilar Market Size to be Worth 13,993.64 Million by 2024 – Zion Market Research

Oncology Biosimilar Market

Oncology Biosimilar Market

Oncology Biosimilar Market expected to generate revenue of around USD 13,993.64 million by end of 2024, growing at a CAGR of around 26.8% between 2018 and 2024

Oncology Biosimilar Market To Report Impressive Growth, Revenue To Surge To US$ 13,993.64 Million By 2024”

— Zion Market Research

NEW YORK, NEW YORK, UNITED STATES, February 26, 2020 /EINPresswire.com/ — Zion Market Research has published a new report titled “Oncology Biosimilar Market by Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, and Others), By Drug Type (mAb, Immunomodulators, Hematopoietic Agents, G-CSF, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024”. According to the report, global oncology biosimilar market was valued approximately USD 2655.19 million in 2017 and is expected to generate revenue of around USD 13,993.64 million by end of 2024, growing at a CAGR of around 26.8% between 2018 and 2024.

Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These molecules are cost-effective, efficient, and have the same ability as biologics. These molecules are easy to manufacture as compared to biologics and can only be manufactured after patent expiry. Earlier there were various patented biologics available in the market but nowadays most of the patents have expired and few are on the verge of patent expiry. In the past few years, various biosimilars have been approved by FDA for the treatment of various types of cancer such as blood cancer, colorectal cancer, breast cancer, and others. In the near future, it is expected that a few more biosimilars will be introduced in the market thus supporting the growth of the market.

Get Free Research Report Sample PDF – https://www.zionmarketresearch.com/requestbrochure/oncology-biosimilar-market

Oncology biosimilar market is primarily driven by the increased prevalence of cancer, which has led to the increased demand for affordable therapies for the treatment of cancer. There are various pharmaceutical companies available in the market which are involved in the manufacturing of biosimilar. Patent expiry is also one of the major driving factors for the oncology biosimilar market. Patent expiry will provide an opportunity to the pharmaceutical companies to manufacture more biosimilars which will fuel the market growth in the near future. Increased demand for the healthcare facilities and rapid approval of biosimilars will support the growth of oncology biosimilar market in the near future.

Oncology biosimilar market is segmented on the basis of different types of cancer such as breast cancer, colorectal cancer, blood cancer, neutropenia cancer, non-small cell lung cancer, and others. On the basis of drug type, the market is segmented into mAb, immunomodulators, hematopoietic agents, G-CSF, and others. G-CSF is expected to grow at the fastest rate in the global market over the forecast period. On the basis of the distribution channel, the market is segmented into retail pharmacies, hospital pharmacy, and online pharmacy. Hospital pharmacy is expected to grow at the fastest rate over the forecast period.

Browse full Report TOC for more Industry Insights – https://www.zionmarketresearch.com/toc/oncology-biosimilar-market

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa are key regional segments of global oncology biosimilar market. North America is anticipated to remain the leading region over the forecast period. Demand for oncology biologics was highest in North America especially in the U.S. Asia Pacific is expected to be the fastest growing region in the oncology biosimilar market during the forecast period. Moreover, the Middle East and Africa and Latin America are also expected to show considerable growth for this market in the years to come.

Some of the key players in oncology biosimilar market include Teva Pharmaceutical Industries Ltd., Biocon, STADA Arzneimittel AG, Sandoz International GmbH, Intas Pharmaceuticals Ltd., Celltrion Inc., Pfizer Inc., Apotex Inc., Dr. Reddy’s Laboratories Ltd., and BIOCAD, among others.

This report segments the global oncology biosimilar market as follows:

Global Oncology Biosimilar Market: Test Type Segment Analysis:

Breast Cancer
Colorectal Cancer
Blood Cancer
Neutropenia Cancer
Non-Small Cell Lung Cancer
Others

Global Oncology Biosimilar Market: Drug Type Segment Analysis:

mAb
Immunomodulators
Hematopoietic Agents
G-CSF
Others

Global Oncology Biosimilar Market: Distribution Channel Analysis:

Retail Pharmacies
Hospital Pharmacy
Online Pharmacy

Global Oncology Biosimilar Market: Regional Analysis:

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa

Browse Press Release: https://www.zionmarketresearch.com/news/oncology-biosimilar-industry

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Kalpesh Deshmukh
Zion Market Research
+1 855 465 4651
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

SURF THERAPY – THE NATURAL WAY TO BEAT CYSTIC FIBROSIS ONE DAY AT A TIME WITH MAULI OLA AND SAFEGROM

SafeGrom and Mauli Ola team up for children to beat Cystic Fibrosis

SafeGrom and Mauli Ola team up for children to beat Cystic Fibrosis. Athletes: Brian Ortega and Hans Hagen

Mauli Ola and SafeGrom are teaming up to help children beat Cystic Fibrosis one day at a time with surf events.

LAGUNA BEACH, CA, USA, February 26, 2020 /EINPresswire.com/ — SafeGrom and Mauli Ola Foundation team up with in hosting Surf Experience Days and create relief to children suffering from Cystic Fibrosis.

CYSTIC FIBROSIS

Cystic Fibrosis is an inherited genetic disease that interferes with the respiratory, digestive and reproductive systems of the body. The mutation of a specific gene (the CFTR) causes the production of a sticky, thick mucus. This builds up and clogs the small airways that carry harmful bacteria out of the body causing serious infection and putting constant stress on the immune system.

LIVING WITH CYSTIC FIBROSIS

Medical advances mean better and more effective treatments and are available today to help children and adults with cystic fibrosis live more comfortably. But effective management of the disease requires a variety of medications that are costly; treatment regimens are demanding, and depending on the extent and severity of the disease, normal childhood activities are often disrupted by daily therapy and lengthy hospital admissions.

NATURAL THERAPIES FOR CYSTIC FIBROSIS RELIEF

Thankfully though medication is not the only treatment for Cystic Fibrosis. Research from the Cystic Fibrosis Foundation (CFF) is showing that young surfers with cystic fibrosis had significantly healthier lungs than normal children with cystic fibrosis. The doctors determined that inhaling salt water mist has a powerful effect on rehydrating the lining of lungs and allowing Cystic Fibrosis patients to more easily remove bacteria-contaminated mucus.

THE MAULI OLA FOUNDATION

The Mauli Ola Foundation is a non-profit organization dedicated to providing hope and confidence to individuals living with genetic diseases. Harnessing the healing powers of the ocean, the Mauli Ola Foundation promotes surfing and ocean-based activities as natural therapies.

The goal for the Mauli Ola Foundation is that these salt water experiences not only reduce hospital visits but expose children to a healthy lifestyle leading to a more fulfilling life that all kids should experience.

“The surf experience day gave our family an opportunity to forget the daily demands that this disease has on us.”
– Martha (CF mom)

SURF EXPERIENCE DAYS

The Mauli Ola Foundation was started to take kids with Cystic Fibrosis surfing so they can experience what natural therapies can do for their lungs. Not only will they feel the saline content in the ocean air and water break down congestion in their lungs, the exercise will also help them to strengthen their lungs and expel mucous.

“I leave from a surf session with the ability to take a deep breath and the satisfaction that I just conquered Cystic Fibrosis for the day.”
– Caleb (CF surfer)

"The Mauli Ola Foundation gives our Cystic Fibrosis patients the opportunity to better understand how both exercise and exposure to salty water can help them improve their health".
– Dr. Bruce Ong, (Chief of Pediatric Pulmonology, Tripler Army Medical Center)

SAFEGROM AND MAULI OLA FOUNDATION

The SafeGrom StokeVest is equipped with a handle on the back and was created to maximize the safety of children in the water. SafeGrom is the proud sponsor for the Mauli Ola Surf Experiences Days.

"Having a specialized product for getting kids in and out of the water is a game changer for us! It takes our surf experiences to the next level and in one day we can see the confidence in our kids grow in their surf ability and also their ability to battle CF!!"
– Hans Hagen, (Executive Director of Mauli Ola Foundation)

Next Mauli Ola Surf Experience Days event is on April 19, 2020 in Huntington Beach, California.

Tim Ryan
SafeGrom LLC
949-554-5015
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Wyoming US Navy Veterans Lung Cancer Advocate Urges the Family of a Navy Veteran with Lung Cancer in Wyoming Who Also Had Heavy Asbestos Exposure to Call for Direct Access the Lawyers at Karst von Oiste-Get Compensated

"To assist a Navy Veteran or person with lung cancer in Wyoming who also had heavy exposure to asbestos we have endorsed the law firm of Karst von Oiste to get the compensation job done. ”

— Wyoming US Navy Veterans Lung Cancer Advocate

CHEYENNE, WYOMING, USA, February 26, 2020 /EINPresswire.com/ — The Wyoming US Navy Veterans Lung Cancer Advocate is urging the family of a Navy Veteran with lung cancer anywhere in Wyoming to call them anytime at 800-714-0303 if the Veteran had heavy exposure to asbestos in the navy or afterwards. Financial compensation for people like this can exceed a hundred thousand dollars. Even if the person smoked cigarettes, they could receive significant compensation if they have lung cancer and they were exposed to asbestos in the navy or at work.

The Advocate says, "To assist a Navy Veteran or person with lung cancer in Wyoming who also had heavy exposure to asbestos we have endorsed the law firm of Karst von Oiste. The lawyers at the law firm of Karst von Oiste are responsible for over a billion dollars in financial compensation for people with asbestos exposure lung cancer and mesothelioma and they work overtime for their clients. For direct access to the lawyers at the law firm of Karst von Oiste please call 800-714-0303." www.karstvonoiste.com/

The Wyoming US Navy Veterans Lung Cancer Advocate is offering the following free services for a Navy Veteran or person with asbestos exposure lung cancer in Wyoming or anywhere in the United States:

* “We will assist with VA Disability payments for Navy Veterans.”

* “We will assist a Navy Veteran or person with asbestos exposure lung cancer get organized about how, where and when they were exposed to asbestos. We call this service the ‘list’ and it is this information that becomes the basis for an asbestos exposure lung cancer compensation claim as we would like to discuss at 800-714-0303." https://Wyoming.USNavyLungCancer.Com

The Wyoming US Navy Veterans Lung Cancer Advocate's free services are available to people with asbestos exposure lung cancer or mesothelioma in Cheyenne, Casper, Laramie, Gillette,Jackson Hole. Rock Springs or anywhere in Wyoming.

High-risk work groups for exposure to asbestos in Wyoming include US Navy Veterans, workers at one of Wyoming’s power plants, oil refinery workers, steel mill workers, pulp and paper mill workers, manufacturing workers, industrial workers, public utility workers, plumbers, electricians, auto mechanics, machinists, or miners. Typically, the exposure to asbestos occurred in the 1950’s, 1960’s, 1970’s, or 1980’s. https://Wyoming.USNavyLungCancer.Com

According to the American Cancer Society for nonsmokers who have been exposed to asbestos in their workplace the risk of lung cancer is five times that of unexposed workers. https://www.cdc.gov/cancer/lung/statistics/index.htm.

The US Navy Veterans Lung Cancer Advocate says, "If your husband, dad, coworker or neighbor has just been diagnosed with lung cancer and you know they had significant exposure to asbestos in the navy, at a shipyard or while working at a factory, at power plant, public utility, or as a plumber, electrician welder, mechanic or any kind of skilled trades group in any state please have them call us anytime at 800-714-0303. Most people like this never get compensated-even though the asbestos trust funds were set up for them too. We are trying to change this sad fact." https://USNavyLungCancer.Com

States with the highest incidence of lung cancer include Kentucky, West Virginia, Maine, Tennessee, Mississippi, Ohio, Indiana, Louisiana, Arkansas, Missouri, North Carolina, Rhode Island, Alabama, and Delaware. www.karstvonoiste.com/

For more information about asbestos exposure please visit the NIH's website on this topic: https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/asbestos/asbestos-fact-shee

Michael Thomas
Wyoming US Navy Veterans Lung Cancer Advocate
+1 800-714-0303
email us here


Source: EIN Presswire

John Davis joins Panther Medical as a Business Advisor

AJAX, ONTARIO, CANADA, February 26, 2020 /EINPresswire.com/ — Panther Medical Canada Inc. (PMC) the 3rd largest Global Surgical Stapling Company today announced that John Davis has joined the company as a Business Advisor and shareholder, effective February 18, 2020.

“John Davis is highly accomplished executive who brings a wealth of experience that will help us accelerate our strategy,” said Mario Cortis, President of PMC. “John has extensive expertise particularly in the Stapling and Minimally Invasive Surgery space. We are excited to welcome him as part of our team.”

Since leaving Medtronic Inc. in 2015, where John served as Vice President, Sales and Marketing, John has worked with several start-ups in the healthcare space as CEO, Board Chairman, Advisor and Investor. Prior to Medtronic, John took many senior leadership roles in companies like Stryker, Karl Storz and Johnson & Johnson Ethicon Endo Surgery.

About Panther Medical Canada Inc:
Ajax, Ontario based Panther Medical Canada offers a full range of high-quality surgical instrumentation products as used in Gastric, Digestive, Esophageal, Pancreatic, Gynecological, Thoracic and General surgical procedures. By partnering with Canadian surgeons, nurses, researchers and payers in training, innovation, research and development and by delivering millions of dollars in missing economic value, Panther Medical Canada aspires to bring efficiencies back to Canadian Healthcare Payers, and improve patient lives.
For more information, visit www.panthermedical.ca

Avinash Sohal
Panther Medical Canada Inc
+1 647-544-0618
email us here
Visit us on social media:
LinkedIn


Source: EIN Presswire

Iowa US Navy Veterans Mesothelioma Advocate Has Endorsed Attorney Erik Karst of Karst von Oiste to Make Certain a Navy Veteran with Mesothelioma in Iowa Receives an Unsurpassed Financial Compensation Settlement

The Advocate has endorsed Erik Karst and his colleagues at the law firm of Karst von Oiste to ensure a Navy Veteran with mesothelioma in Iowa receives the best possible financial compensation results.”

— Iowa US Navy Veterans Mesothelioma Advocate

DES MOINES , IOWA, USA, February 26, 2020 /EINPresswire.com/ — The Iowa US Navy Veterans Mesothelioma Advocate has endorsed attorney Erik Karst and his remarkable colleagues at the law firm of Karst von Oiste to ensure a Navy Veteran with mesothelioma receives the best possible financial compensation results as they would like to discuss at 800-714-0303. Erik Karst and his colleagues have been assisting Navy Veterans and people with mesothelioma for decades and they are responsible for over a billion dollars in financial compensation results for people like this.

The lawyers at the law firm of Karst von Oiste also make house calls anywhere in Iowa to ensure the Navy Veteran and their family understand how the mesothelioma compensation process works and what the Veteran's compensation claim could be worth. For direct access to attorney Erik Karst of the law firm of Karst von Oiste please call 800-714-0303 anytime. www.karstvonoiste.com/

The Iowa US Navy Veterans Mesothelioma Advocate says, "We have endorsed attorney Erik Karst of the law firm of Karst von Oiste because we know how committed he and his colleagues are to making ensuring a Navy Veteran with mesothelioma receives the best possible financial compensation results. Erik Karst or his colleagues at the law firm of Karst von Oiste do not need outside assistance to make certain a Navy Veteran with mesothelioma receives the best possible financial compensation results. Before a Navy Veteran with mesothelioma in Iowa hires a lawyer to assist with mesothelioma compensation please call us at 800-714-0303." https://Iowa.USNavyMesothelioma.Com

The Iowa US Navy Veterans Mesothelioma Advocate is offering the following free services for a Navy Veteran with mesothelioma in Iowa:

* “We will assist with VA Disability payments.”

* “We will assist a Navy Veteran with asbestos exposure lung cancer get organized about how, where and when they were exposed to asbestos. We call this service the ‘list’ and it is this information that becomes the basis for a mesothelioma compensation claim as we would like to discuss at 800-714-0303.”
https://Iowa.USNavyMesothelioma.Com

The US Navy Veterans Mesothelioma Advocate’s services are available to US Navy Veterans with mesothelioma in Des Moines, Cedar Rapids, Davenport, Sioux City, Waterloo, Iowa City, Council Bluffs, Dubuque or anywhere in Iowa. https://Iowa.USNavyMesothelioma.Com

For the best possible mesothelioma treatment options in Iowa the Iowa US Navy Veterans Mesothelioma Advocate strongly recommends the following heath care facility with the offer to help a diagnosed victim, or their family get to the right physicians at this hospital.

* Holden Comprehensive Cancer Center Iowa City, Iowa: https://cancer.uiowa.edu/.

The states with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. www.karstvonoiste.com/

For a listing of various classes of US Navy ships or submarines please visit the US Navy website on this topic: https://www.navy.mil/navydata/our_ships.asp.

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma

Michael Thomas
Iowa US Navy Veterans Mesothelioma Advocate
+1 800-714-0303
email us here


Source: EIN Presswire

RegScan Launching Artificial Intelligence, Mobile, Enhanced Compliance Research

RegScan, Inc Logo

RegScan, Inc.

Our new interface is a giant leap forward in making it easier to access the answers our users need to do their jobs…”

— Ned Ertel

WILLIAMSPORT, PA, UNITED STATES, February 26, 2020 /EINPresswire.com/ — RegScan, Inc., a compliance management company, is launching a new regulatory platform. The new platform has a mobile-friendly interface which allows you to easily access the content you know and trust on any device. With this interface, we also added enhancements to better support your experience, including:

• AI-supported search engine to get you to the information you need faster than ever

• Increased functionality with quick access toolbar and saved searches

• User-friendly navigation with new mega-menu and dashboard

• Guided registration for new users with simplified email domain registration and single-sign-on (SSO) options

• State-of-the-art privacy tools

“Our new interface is a giant leap forward in making it easier to access the answers our users need to do their jobs,” said RegScan President and CEO, Ned Ertel. RegScan’s growing content library contains more than 175 jurisdictions and twelve languages to keep you covered anywhere you operate.

ABOUT REGSCAN

With a dedicated staff of experts, an ever-growing network of in-country sources, and 30 years of experience, RegScan is a trusted resource for up-to-date EHS regulatory information from all over the world. RegScan's unique toolset allows users to access global environmental regulations on a single site, provides alerts on regulatory changes, customizes audit checklists, and facilitates content integration with major environmental management systems.

Ned Ertel
RegScan, Iinc.
+1 202-548-2811
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

The Internet: Are Children In Charge?

Proactive Online Child Protection

Digital Supervision – Proactive Online Child Protection

Author, Charlene Doak-Gebauer

Many people are worried about child safety online, and should be. The statistics speak for themselves. Read about parental proactive Digital Supervision.

The Internet hosts more predation than any host in the history of the world.”

— Charlene Doak-Gebauer

LONDON, ONTARIO, CANADA, February 26, 2020 /EINPresswire.com/ — Author, Charlene Doak-Gebauer
FOR IMMEDIATE RELEASE
DATE: February 26, 2020

The Internet: Are Children In Charge?

LONDON, ON Canada – “I wonder who is looking at my picture today? I just want to kill myself”, sobs a 13-year old teen who sent a nude of herself to her boyfriend, who circulated the picture throughout their school. Who knows how far it went outside the school?

“I wonder if I will get in trouble for talking so much to that guy on my game? I told him where I live. I know he is a lot older and he sent me nude”, thinks an eight-year old after gaming online with an adult.

“Am I going to be in trouble? I was watching my cartoon online and saw naked adults doing weird things”, wondered a scared six-year old after being exposed to xxx pornography online.

Are children in charge of the Internet? In most cases, yes, they are in charge in their homes. Are you aware of what your child is viewing online? Do you know who is chatting with your child online? Do they know? Are you aware there are young children addicted to pornography? These types of situations, self-exploitation or predation, are becoming an epidemic worldwide.

Do we know how to digitally supervise a child in our care? Son? Daughter? Charlene Doak-Gebauer says this generation is the most independent generation in the history of the world because of the Internet and digital devices. What can be done to assist children as they mature in this digital age?

As a Computer Specialist and Network Administrator in education, Doak-Gebauer has created her user-friendly Theory of Digital Supervision for online child protection. Why is it necessary?

The online vulnerabilities of our children have increased by 10,000% (Thorn) in the past few years because of the Internet and actions of unknowns, knowns, and our children. In addition to unknowns, our children have become victimizers because of their exposure to so much inappropriate content online.

According to Heidi Olson, Kansas City, child-on-child sexual assault has become staggering in numbers in their pediatric trauma unit at Mercy Hospital. There has been a direct correlation established between a child viewing pornography and becoming a child-on-child sexual assault perpetrator. In fact, according to Finkelhor (et al 2014), a large research study showed that anywhere from one third to half of all perpetrators are juveniles.

In her recently published book, “The Internet: Are Children In Charge?”, Charlene Doak-Gebauer impresses upon everyone globally – “catching up to the digital age is a necessity for the sake of our children, in every country of the world”. The addition of Digital Supervision to our already excellent traditional parenting skills, will enhance our child protection abilities.

Through research, Doak-Gebauer has found that exposure to our children of pornography and other inappropriate content online, is becoming a very real threat to the health of children – some addicted to pornography; some unknowingly producing and distributing child pornography; some performing sexual assaults on other children; some having erectile dysfunction as male teens caused by porn addiction; some planning suicides online; some bullying and threatening peers online; some planning gang attacks online; some planning violent acts to public safety online, and more.

Digital Supervision is written as a proactive approach to online child safety. Doak-Gebauer explains, “We cannot depend on ISP’s, police, governments, social media managers and others to protect our children online. We must supervise our children while they are on digital devices in our homes and schools”.

Too often, people have said “these kids have to make better choices online!!”. Groups go into schools trying to teach children to make better decisions while on digital devices. Doak-Gebauer says children are being given too much ownership for their decisions, particularly online. An eight-year old has little choice as to what to have for dinner, and yet they are supposed to make the right choices while communicating online. They lack the life skills and maturity to do so effectively.

Laws can change in countries, but without method, parents are at a loss. There are age-appropriate design codes in place in Britain. Unfortunately, there can be gaps in the codes. Doak-Gebauer warns that children can find the gaps and still view inappropriate material. Digital Supervision provides a technology/humanity bond for child protection. Too often, Doak-Gebauer cautions that hardware filters, design codes, and software blocking provide a false sense of security for parents. Expansion of supervision including digital methods are necessary. Read her user-friendly book to learn how to protect children, digitally. Doak-Gebauer asks that we work together for the sake of this generation.

In addition to being an award-winning speaker and author, Doak-Gebauer is the Founder and Chair of a dynamic, philanthropic speaking team, dedicated to speaking about her Theory of Digital Supervision for online child protection. It is called “The Anti Internet Child Exploitation Team – AICET”, with Americans and Canadians on the team. She maintains we should work in solidarity for the protection of all children globally, without borders. The AICET Council works for expenses only and can provide a half-day or full-day conference. If full day, attendees are eligible for a Certificate of Completion for Digital Supervision training. To learn more, go to the AICET Council brochure at Internet Sense First, the charity for which Doak-Gebauer is Founder and Chair.
.

Charlene’s book “The Internet: Are Children In Charge?” is available on Amazon, Chapters, Indigo, Coles, 40,000 distribution channels worldwide.

Charlene Doak-Gebauer
Internet Sense First
+1 519-854-1249
email us here
Visit us on social media:
Facebook
LinkedIn

The Internet: Are Children In Charge? Yes, they are in most cases.


Source: EIN Presswire

North Carolina Mesothelioma Victims Center Now Urges A Navy Veteran or Person with Mesothelioma in North Carolina to Call for Direct Access to Attorney Erik Karst of the KVO Law Firm-Get Better Compensation results

North Carolina

"The lawyers at the law firm of Karst von Oiste make house calls anywhere in North Carolina to ensure a person with mesothelioma understands the compensation process and the value of their claim. ”

— North Carolina Mesothelioma Victims Center

CHARLOTTE , NORTH CAROLINA, USA, February 26, 2020 /EINPresswire.com/ — The North Carolina Mesothelioma Victims Center is urging a Navy Veteran or a person with mesothelioma in North Carolina to call them anytime at 800-714-0303 for direct access to attorney Erik Karst of the law firm of Karst von Oiste. Attorney Erik Karst and his colleagues at the law firm of Karst von Oiste are responsible for over a billion dollars in financial compensation for Navy Veterans and people with mesothelioma in North Carolina and nationwide and they work overtime for their clients. The lawyers at the law firm of Karst von Oiste also make house calls anywhere in North Carolina to ensure a person with mesothelioma and or their family understand the financial compensation process and the potential value of their claim. www.karstvonoiste.com/

According to the North Carolina Mesothelioma Victims Center, "The biggest mistake a person with mesothelioma in North Carolina or their family can make is to start ordering 'free' books, kits, guides and or calculators-because these are tactics law firms use to identify people with mesothelioma. Frequently the person with mesothelioma is unprepared for the tidal wave of lawyer phone calls ordering something 'free' can cause as we would be happy to discuss at 800-714-0303.

"If you call us at 800-714-0303 and tell us a little bit about how the person with mesothelioma was exposed to asbestos, we will have attorney Erik Karst call you back so you can discuss compensation with a national expert. If you like Erik-he or one of his colleagues will come to your home for a more in-depth conversation about how, where and when the person's asbestos exposure took place. It is this information that becomes the basis for a mesothelioma compensation claim and it is incredibly important-as we would be happy to discuss anytime." https://NorthCarolina.MesotheliomaVictimsCenter.Com

The North Carolina Mesothelioma Victims Center wants to emphasize their campaign is a statewide initiative available to a diagnosed victim of mesothelioma anywhere in North Carolina including communities such as Raleigh, Winston-Salem, Charlotte, Greensboro, Fayetteville, Asheville, or Wilmington. www.karstvonoiste.com/

Aside from offering instant access to the nation’s most skilled mesothelioma lawyers the Center is offering the best possible mesothelioma treatment options in North Carolina. The North Carolina Mesothelioma Victims Center strongly recommends the following three heath care facilities with the offer to help a diagnosed victim or their family get to the right physicians at each hospital.

* The North Carolina Mesothelioma Victims Center recommends the Duke Cancer Institute Durham, North Carolina: http://www.dukecancerinstitute.org/

* The UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina: https://unclineberger.org/

* Comprehensive Cancer Center Winston-Salem North Carolina: https://www. wakehealth.edu/Comprehensive-Cancer-Center/

The North Carolina Mesothelioma Victims Center says, “High-risk work groups for exposure to asbestos in North Carolina include Veterans of the US Navy, power plant workers, shipyard workers, steel mill workers, oil refinery workers, pulp, or paper mill workers, factory workers, plumbers, electricians, miners, auto mechanics, machinists, and construction workers.” www.karstvonoiste.com/

The states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. However, mesothelioma does happen in North Carolina. www.karstvonoiste.com/

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma

Michael Thomas
North Carolina Mesothelioma Victims Center
+1 800-714-0303
email us here


Source: EIN Presswire